Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Development of Culturally-Sensitive and Patient-Centered Feedback for Alzheimer's Dementia Risk Disclosure
Authors not listed
University of Michigan · 2021
Abstract
The goal of this study is to test efficacy and safety of person-centered, culturally-informed protocols for disclosure of different combinations of Alzheimer's dementia risk factors. Building on the results from a federally-funded assessment of preferences and needs of racially diverse participants and their respective friends/family members, in regard to Dementia - Alzheimer's Type (DAT), we have produced protocols for communication of DAT risk, with attention to specific adaptations in style or content based on individual factors and preferences. These protocols allow for communication of risk based on clinical history and diagnosis, structural neuroimaging, apolipoprotein-E status, and amyloid and tau burden on positron emission tomography. In particular, protocols specify (a) effective methods of communicating risk conferred by each data source, (b) information designed for patients versus informants, (c) psychoeducation needs, and (d) resource/support needs. We will recruit a randomly-selected subset of 10 dyads (including 5 participants who are Non-Hispanic African-American, 5 participants who are Non-Hispanic White) from the Stage I sample to whom we will develop and implement personalized DAT risk disclosure protocols. We will provide preliminary information on the effectiveness of these protocols in terms of patient/co-participant comprehension and recall of feedback provided, and initial changes in mood or behavior immediately following and shortly after risk disclosure sessions.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-23 MST
Cite this
APA
Anonymous. (2021). Development of Culturally-Sensitive and Patient-Centered Feedback for Alzheimer's Dementia Risk Disclosure. <em>University of Michigan</em>. https://clinicaltrials.gov/study/NCT04309500
Vancouver
Anonymous. Development of Culturally-Sensitive and Patient-Centered Feedback for Alzheimer's Dementia Risk Disclosure. University of Michigan. 2021.
BibTeX
@misc{anon2021Develo,
title = {Development of Culturally-Sensitive and Patient-Centered Feedback for Alzheimer's Dementia Risk Disclosure},
author = {Anonymous},
journal = {University of Michigan},
year = {2021},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Istanbul Medipol University Hospital 2022
Open access · US-GOV
Development of a Sensory Entrainment-Integrated Cognitive Game Kit to Improve Cognitive Functions in Alzheimer's Disease
Texas ScholarWorks (Texas Digital Library) 2014
Preprint · OA
Inhibiting amyloid precursor protein to prevent neurodegeneration in Down syndrome and Alzheimer's disease
Journal of Atherosclerosis and Thrombosis 2023
Open access · CC-BY
Cardiovascular Risk Age Reflects Arterial Status: Middle-Aged People Showed Equivalent Arterial Stiffness to Older People in the Same Risk Category
Journal of Alzheimer s Disease 2018
Open access · CC-BY
The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade
University Hospital, Bordeaux 2019
Open access · US-GOV
Memento-Plus : Long-term Follow-up of Cognitive and Functional Evolutions of Persons With Isolated Cognitive Complaints or Mild Cognitive Deficits
Universidad Nacional de Educación a Distancia 2015
Open access · US-GOV